Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
According to our Researcher latest study, the global End Stage Renal Disease Treatment market size was valued at USD 56940 million in 2022 and is forecast to a readjusted size of USD 81330 million by 2029 with a CAGR of 5.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.
This report is a detailed and comprehensive analysis for global End Stage Renal Disease Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global End Stage Renal Disease Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global End Stage Renal Disease Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global End Stage Renal Disease Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global End Stage Renal Disease Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for End Stage Renal Disease Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global End Stage Renal Disease Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius, DaVita, Baxter, Nipro and B. Braun, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
End Stage Renal Disease Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Market segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
Market segment by players, this report covers
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe End Stage Renal Disease Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of End Stage Renal Disease Treatment, with revenue, gross margin and global market share of End Stage Renal Disease Treatment from 2018 to 2023.
Chapter 3, the End Stage Renal Disease Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and End Stage Renal Disease Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of End Stage Renal Disease Treatment.
Chapter 13, to describe End Stage Renal Disease Treatment research findings and conclusion.
According to our Researcher latest study, the global End Stage Renal Disease Treatment market size was valued at USD 56940 million in 2022 and is forecast to a readjusted size of USD 81330 million by 2029 with a CAGR of 5.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Fresenius is one of the most important global key players of the end stage renal disease treatment, holds about 20% of shares of the global end stage renal disease treatment market, other key players include DaVita, Baxter, etc. North America is the largest market, occupied for about 40 percent, followed by the Asia Pacific. In terms of type, hemodialysis is the largest segment, with a share of about 70%, and in terms of application, the kidney dialysis centers segment holds a share of over 60 percent.
This report is a detailed and comprehensive analysis for global End Stage Renal Disease Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global End Stage Renal Disease Treatment market size and forecasts, in consumption value ($ Million), 2018-2029
Global End Stage Renal Disease Treatment market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global End Stage Renal Disease Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global End Stage Renal Disease Treatment market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for End Stage Renal Disease Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global End Stage Renal Disease Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius, DaVita, Baxter, Nipro and B. Braun, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
End Stage Renal Disease Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Market segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
Market segment by players, this report covers
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe End Stage Renal Disease Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of End Stage Renal Disease Treatment, with revenue, gross margin and global market share of End Stage Renal Disease Treatment from 2018 to 2023.
Chapter 3, the End Stage Renal Disease Treatment competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and End Stage Renal Disease Treatment market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of End Stage Renal Disease Treatment.
Chapter 13, to describe End Stage Renal Disease Treatment research findings and conclusion.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
